Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats

被引:18
作者
Bell, D [1 ]
Zhao, YY [1 ]
Kelso, EJ [1 ]
McHenry, EM [1 ]
Rush, LM [1 ]
Lamont, VM [1 ]
Nicholls, DP [1 ]
McDermott, BJ [1 ]
机构
[1] Queens Univ Belfast, Div Med & Therapeut, Sch Med, Cardioendocrine Res Grp, Belfast BT9 7BL, Antrim, North Ireland
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2006年 / 290卷 / 02期
关键词
nitric oxide; receptor activity-modifying proteins; acetoxymethyl ester; N omega-nitro-L-arginine methyl ester;
D O I
10.1152/ajpheart.00152.2005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats. Am J Physiol Heart Circ Physiol 290: H904-H914, 2006. First published July 22, 2005; doi:10.1152/ajpheart.00152.2005.-Adrenomedullin may provide a compensatory mechanism to attenuate left ventricular hypertrophy (LVH). Nitric oxide synthase inhibition, induced by chronic administration of N-omega-nitro-L-arginine methyl ester (L-NAME) to rats, induces cardiac hypertrophy in some, but not all cases; there are few reports of direct assessment of cardiomyocyte parameters. The objective was to characterize hypertrophic parameters in left (LV) and right ventricular (RV) cardiomyocytes after administration of L-NAME to rats for 8 wk and to determine whether adrenomedullin and its receptor components were upregulated. After treatment with L-NAME (20 and 50 mg(.)kg(-1.)day(-1)), compared with nontreated animals, 1) systolic blood pressure increased (by 34.2 and 104.9 mmHg), 2) heart weight-to-body wt ratio increased 24.1% at the higher dose (P < 0.05), 3) cardiomyocyte protein mass increased (P = NS), 4) cardiomyocyte protein synthesis ([C-14] phenylalanine incorporation) increased (P < 0.05), 5) expression of skeletal alpha-actin, atrial natriuretic peptide, brain natriuretic peptide, and ET-1 mRNAs was enhanced (P < 0.05) in LV but not RV cardiomyocytes at 20 and 50 mg(.)kg(-1.)day(-1), respectively, and 6) expression of adrenomedullin, receptor activity-modifying protein 3 (RAMP3), and RAMP2 (but not calcitonin receptor-like receptor and RAMP1) mRNAs was increased by L-NAME (20 mg(.)kg(-1.)day(-1)) in LV. In conclusion, L-NAME enhanced protein synthesis in both LV and RV cardiomyocytes but elicited a hypertrophic phenotype accompanied by altered expression of the counterregulatory peptide adrenomedullin and receptor components (RAMP2, RAMP3) in LV only, indicating that the former is due to impaired nitric oxide synthesis, whereas the phenotypic changes are due to pressure overload.
引用
收藏
页码:H904 / H914
页数:11
相关论文
共 64 条
[1]   Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis [J].
Akuzawa, N ;
Nakamura, T ;
Kurashina, T ;
Saito, Y ;
Hoshino, J ;
Sakamoto, H ;
Sumino, H ;
Ono, Z ;
Nagai, R .
AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (06) :697-707
[2]   CARDIAC WEIGHT IN HYPERTENSION INDUCED BY NITRIC-OXIDE SYNTHASE BLOCKADE [J].
ARNAL, JF ;
ELAMRANI, AI ;
CHATELLIER, G ;
MENARD, J ;
MICHEL, JB .
HYPERTENSION, 1993, 22 (03) :380-387
[3]   Adrenomedullin signalling in cardiomyocytes is dependent upon CRLR and RAMP2 expression [J].
Autelitano, DJ ;
Ridings, R .
PEPTIDES, 2001, 22 (11) :1851-1857
[4]   Hypertension without cardiac hypertrophy does not induce a cardiac baroreflex deficit [J].
Banting, JD ;
Wiseman, SL ;
Adams, MA .
JOURNAL OF HYPERTENSION, 1996, 14 (10) :1209-1214
[5]   Chronic NG-nitro-L-arginine methyl ester-induced hypertension -: Novel molecular adaptation to systolic load in absence of hypertrophy [J].
Bartunek, J ;
Weinberg, EO ;
Tajima, M ;
Rohrbach, S ;
Katz, SE ;
Douglas, PS ;
Lorell, BH .
CIRCULATION, 2000, 101 (04) :423-429
[6]   Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive rat [J].
Bayraktutan, U ;
Yang, ZK ;
Shah, AM .
CARDIOVASCULAR RESEARCH, 1998, 38 (03) :719-726
[7]   Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat [J].
Bell, D ;
Kelso, EJ ;
Argent, CCH ;
Lee, GR ;
Allen, AR ;
McDermott, BJ .
CARDIOVASCULAR PATHOLOGY, 2004, 13 (02) :71-78
[8]   HYPERTROPHIC EFFECTS OF CALCITONIN-GENE-RELATED PEPTIDE (CGRP) AND AMYLIN ON ADULT MAMMALIAN VENTRICULAR CARDIOMYOCYTES [J].
BELL, D ;
SCHLUTER, KD ;
ZHOU, XJ ;
MCDERMOTT, BJ ;
PIPER, HM .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1995, 27 (11) :2433-2443
[9]   Effect of captopril in L-name-induced hypertension on the rat myocardium, aorta, brain and kidney [J].
Bernátová, I ;
Pecháñová, O ;
Simko, F .
EXPERIMENTAL PHYSIOLOGY, 1999, 84 (06) :1095-1105
[10]   Regression of chronic L-NAME-treatment-induced left ventricular hypertrophy:: Effect of captopril [J].
Bernatova, I ;
Pechánová, O ;
Pelouch, V ;
Simko, F .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (02) :177-185